Fluidigm INITIATED at Buy and 2 Analyst-Initiated Shares on the Move

Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on August 31st.

Fresenius Medical (NYSE:FMS): HSBC Securities initiated coverage of this company with a rating of Overweight.

Don’t Miss: Are Home Prices RECOVERING?

BG Medicine (NASDAQ:BGMD): Mizuho initiated coverage of this company with a rating of Buy and a price target of $6.

Fluidigm (NASDAQ:FLDM): Mizuho initiated coverage of this company with a rating of Buy and a price target of $17.

Don’t Miss: Here’s Why Facebook Should Follow Pandora’s Business Model.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>